Search results
Who Is Namita Thapar, Shark Tank Judge Set To Earn Rs 127 Crore From IPO
NDTV· 4 hours agoEntrepreneur Namita Thapar is set to reap a remarkable 293x return on her initial investment in...
Shark Tank India: If you’re a fan of “Shark Tank India,” you’ll enjoy these other shows that delve...
The Times of India· 1 day agoEntrepreneurs pitch their business ideas to a panel of venture capitalists, affectionately referred...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 7 hours agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Man recovering from shark bite on the Florida coast in state's third attack in a month
Hindustan Times· 3 days agoOfficials from the Nassau County Sheriff’s Office Marine Unit responding to a distress call Friday...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 2 hours agoThe initial public offering (IPO) of Emcure Pharmaceuticals opens for bidding on Wednesday, July 3...
Shark Tank India Judge Namita Thapar On Trying To Strike Work-Life Balance - News18
News18· 6 days agoShark Tank India judge Namita Thapar often grabs headlines for her opinions. Most recently, she...
Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO
The Economic Times· 2 days agoShark Tank fame Namita Thapar, part of the promoter group of Emcure Pharmaceuticals, will make...
Emcure has better listed pharma alternatives
The Economic Times· 9 hours agoPromoted by the family of Namita Thapar of the 'Shark Tank' fame, Emcure Pharma is the 13th largest player in the Indian pharmaceutical market. The...
Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the...
Livemint· 1 hour agoEmcure Pharmaceuticals IPO sails through first day of bidding smoothly led by non institutional and...
Emcure Pharmaceuticals IPO: Check subscription on Day 1, GMP and other details - The Economic Times
The Economic Times· 2 hours agoThe initial public offer (IPO) of Emcure Pharmaceuticals, which opened earlier today, was booked 66%...